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Abstract: INTRODUCTION Ever since the beginning of cerebral bypass surgery, the role of the bypass
has been debated and indications have changed over the last 5 decades. This systematic literature
research analysed all clinical studies on cerebral bypass that have been published from January 1959 to
January 2020 for their year of publication, country of origin, citation index, role of and indication for
bypass, bypass technique, revascularized territory, flow capacity, and title (for word cloud analysis per
decade). METHODS A systematic literature research was conducted using PubMed, Web of Science,
EMBASE, and SCOPUS databases. All studies that have been published until January 1, 2020, were
included. RESULTS Of 6,013 identified studies, 2,585 were included in the analysis. Of these, n = 1,734
(67%) studies addressed flow-augmentation bypass and n = 701 (27%) addressed flow-preservation bypass.
The most common indication reported for flow augmentation is moyamoya (n = 877, 51%), followed by
atherosclerotic steno-occlusive disease (n = 753, 43%). For flow preservation, the most common indication
is studies reporting on cerebral aneurysm surgery (n = 659, 94%). The increasing popularity of reporting
on these bypass operations almost came to an end with the FDA approval of flow diverters for aneurysm
treatment in 2011. Japan is the country with the most bypass studies (cumulatively published 933
articles), followed by the USA (630 articles) and China (232 articles). DISCUSSION/CONCLUSION
Clinical studies on cerebral bypass surgery have become increasingly popular in the past decades. Since
the introduction of moyamoya as a distinct pathologic entity, Asian countries in particular have a very
active community regarding this disease, with an increasing number of articles published every year.
Studies on bypass for chronic steno-occlusive disease peaked in the 1980s but have remained the main
focus of bypass research, particularly in many European departments. The number of reports published
on these bypass operations significantly decreased after the FDA approval of flow diverters for aneurysm
treatment in 2011.
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Abstract
Introduction: Ever since the beginning of cerebral bypass 
surgery, the role of the bypass has been debated and indica-
tions have changed over the last 5 decades. This systematic 
literature research analysed all clinical studies on cerebral 
bypass that have been published from January 1959 to Janu-
ary 2020 for their year of publication, country of origin, cita-
tion index, role of and indication for bypass, bypass tech-
nique, revascularized territory, flow capacity, and title (for 
word cloud analysis per decade). Methods: A systematic lit-
erature research was conducted using PubMed, Web of Sci-
ence, EMBASE, and SCOPUS databases. All studies that have 
been published until January 1, 2020, were included. Re-
sults: Of 6,013 identified studies, 2,585 were included in the 
analysis. Of these, n = 1,734 (67%) studies addressed flow-
augmentation bypass and n = 701 (27%) addressed flow-
preservation bypass. The most common indication reported 
for flow augmentation is moyamoya (n = 877, 51%), followed 
by atherosclerotic steno-occlusive disease (n = 753, 43%). 
For flow preservation, the most common indication is stud-
ies reporting on cerebral aneurysm surgery (n = 659, 94%). 
The increasing popularity of reporting on these bypass op-
erations almost came to an end with the FDA approval of 
flow diverters for aneurysm treatment in 2011. Japan is the 
country with the most bypass studies (cumulatively pub-
lished 933 articles), followed by the USA (630 articles) and 
China (232 articles). Discussion/Conclusion: Clinical studies 
on cerebral bypass surgery have become increasingly popu-
lar in the past decades. Since the introduction of moyamoya 
as a distinct pathologic entity, Asian countries in particular 
have a very active community regarding this disease, with an 
increasing number of articles published every year. Studies 
on bypass for chronic steno-occlusive disease peaked in the 
1980s but have remained the main focus of bypass research, 
particularly in many European departments. The number of 
reports published on these bypass operations significantly 
decreased after the FDA approval of flow diverters for aneu-
rysm treatment in 2011. © 2021 The Author(s)
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Cerebral revascularization surgery can be categorized 
according to a number of factors. One of the most impor-
tant distinctions concerns the purpose of the bypass: flow-
augmentation versus flow-preservation [1]. Indications for 
flow-augmentation bypass include moyamoya vasculopa-
thy, chronic steno-occlusive disease, and acute ischaemic 
stroke. Indications for flow preservation typically include 
intracranial aneurysm surgery and tumour surgery [2]. 
Furthermore, bypass surgery is categorized into direct, in-
direct, and combined procedures. Indirect procedures rely 
on the overlay of vascularized tissue (i.e., muscle, dura, 
pericranium, and omentum) onto the cerebral cortex to 
promote neoangiogenesis over time and achieve a delayed 
revascularization. By contrast, a direct bypass instantly 
stimulates blood flow to the brain by direct microvascular 
anastomosis between a donor artery (or graft interposi-
tion, i.e., connected to a donor artery) and an intracranial 
recipient artery. Combined procedures consist of applying 
both direct and indirect techniques in the same surgical 
session. Depending on the choice of the donor artery (ex-
tracranial vs. intracranial donor), a direct bypass is further 
classified into extra- to intracranial (EC-IC) versus intra- 
to intracranial (IC-IC). As mentioned above, the donor 
and the recipient artery can be anastomosed with or with-
out graft interposition, depending on the interposition of 
a vascular graft (arterial or venous). The bypass is gener-
ally named after the donor and recipient vessel (i.e., STA-
MCA bypass). Lastly, direct bypass procedures are catego-
rized according to the rate of flow (capacity) the bypass can 
carry: low capacity (<50 mL/min), intermediate (50–100 
mL/min), or high capacity (>100 mL/min) [2–4].
On October 30, 1967, Professor Yasargil famously per-
formed the first microsurgical direct flow-augmentation 
bypass by anastomosing the superficial temporal artery to 
the middle cerebral artery (STA-MCA) of a 20-year-old 
man suffering from Marfan’s syndrome with left M1 seg-
ment occlusion [5–7]. This microsurgical flow-augmen-
tation bypass technique is considered a surgical break-
through and has remained the most frequently used by-
pass technique in the treatment of cerebrovascular disease 
to this day.
Over the past 50 years of intensive bypass research, 
certain questions have been answered, while others re-
main open. Different aspects of the bypass procedure 
have been the focus of publications, and authors have 
claimed diverse issues to play a leading role at different 
points in time. This systemic review aims to provide an 
overview of the entire clinical bypass literature, showing: 
(1) how the number of new articles increased or decreased 
according to the evidence-based medicine and the corre-
sponding grade of recommendation on indication, (2) 
how different countries and continents contributed to the 
subject, and (3) how the role of and the indication for by-
pass has differed over time and among countries.
Methods
Search Strategy
A systematic literature research was conducted using PubMed, 
Web of Science, EMBASE, and SCOPUS databases. All studies avail-
able on the corresponding platforms and published before January 
1, 2020, were included. Search terms included: “intracranial bypass,” 
“cerebral bypass,” “cerebral revascularization,” “brain revascular-
ization,” “extracranial-intracranial bypass,” “extra-to-intracranial 
bypass,” “extracranial intracranial bypass,” “ec-ic bypass,” “intra-
cranial-intracranial bypass,” “intracranial intracranial bypass,” “ic-
ic bypass,” “synangiosis,” “superficial temporal artery to middle ce-
rebral artery bypass,” “sta-mca bypass,” and “sta mca bypass.”
Eligibility Criteria
All articles or video articles reporting original research includ-
ing prospective studies, randomized control trials (RCTs), case se-
ries and case reports, and others with an abstract in English on the 
topic of cerebral bypass were included. Non-original research (such 
as reviews, opinions, letters to the editor, correspondence, confer-
ence papers, and similar articles) and research articles written in a 
language other than English and without a translated abstract were 
excluded. Studies on intestinal bypasses (“duodenal,” “jejunal,” 
“gastric,” or combinations thereof), cardiac bypasses (“cardio” or 
“coronary”), peripheral vascular bypasses (“femoral,” “axillofemo-
ral”), purely extracranial bypasses for revascularization of the sub-
clavian or vertebral arteries (i.e., in the context of aortic arch sur-
gery), and studies on venous bypass were also excluded. Purely ed-
ucational articles (and video articles) that only illustrate preexisting 
techniques without an original research component were also ex-
cluded. Furthermore, all non-clinical articles such as ex vivo ex-
periments, cadaver studies, and animal experiments were excluded.
Analysed Features
Studies were screened for publication year and country of origin. 
In case of international collaborations, the country of origin of the 
last author was considered decisive. The citation index was deter-
mined for every article as given by the Web of Science. Publications 
were dichotomized between flow augmentation and flow preserva-
tion. Indications for flow augmentation included moyamoya vascu-
lopathy, chronic steno-occlusive disease, or acute stroke. For chron-
ic steno-occlusive disease, further differentiation was made between 
chronic ICA stenosis/occlusion, chronic MCA stenosis/occlusion, 
chronic combined ICA and MCA stenosis/occlusion, vertebrobasi-
lar stenosis/occlusion, and other diseases. Furthermore, low-flow 
(<50 mL/min, typically superficial temporal artery or occipital ar-
tery donor), intermediate-flow (50–100 mL/min, typically arterial 
grafts), and high-flow (>100 mL/min, typically venous grafts) by-
passes were distinguished. In addition, articles were categorized ac-
cording to direct and indirect bypasses and a combination of both. 




Lastly, a distinction was made between anterior and vertebrobasilar 
circulation with regard to the revascularized territory.
Data Analysis and Graphs
Search results from all 4 platforms were merged together and 
duplicates were excluded with the endnote function (Endnote X9 
software for Windows, Clarivate Analytics, Philadelphia, PA, 
USA). Two authors (B.E.G. and L.T.) independently screened all 
titles, followed by abstract screening and data extraction (B.E.G., 
L.T., F.V., S.V., V.M., O.B., and N.S.). Disagreements were dis-
cussed to find consensus and the final decision was made by the last 
author (G.E.). Guidelines for Preferred Reporting Items for Sys-
tematic Reviews and Meta-Analyses [8] were strictly followed. Ex-
tracted data were analysed in a descriptive way and summarized in 
graphs. Graphs were drawn with GraphPad Prism, version 8.4.0 for 
Windows (GraphPad Software, Inc., San Diego, CA, USA). To gen-
erate word clouds, words were extracted from all included manu-
script titles by excluding common English stop and linking words 
as well as unspecific terms (e.g., bypass, surgery, surgical, articles, 
report, disease, and cerebral), and by harmonizing different spell-
ings of the same terms. Tokenization functions were used to find 
linked terms. For clarity reasons, only the most common 45 key 
words (which appeared at least 5 times) were plotted. Building and 
plotting were performed using R version 4.0.2 (R Core Team 
[2020], R Foundation for Statistical Computing, Vienna, Austria).
Results
Our combined literature research revealed 11,605 
studies, of which 5,592 articles were identified as dupli-



























































Fig. 1. PRISMA flow chart outlining the screening, exclusion, and inclusion process of studies. After removal of 
5,592 duplicates, 6,013 studies were screened. Of these, 2,108 were excluded during title screening and 1,319 dur-
ing abstract screening. Finally, 2,586 studies were included and analysed. PRISMA, Preferred Reporting Items 





ed after title screening and 1,320 studies after abstract 
screening, because they did not meet the eligibility crite-
ria. Finally, 2,585 studies were included for data extrac-
tion. The flow chart in Figure 1 shows the numbers of all 
included and excluded studies.
Since the first studies on bypass procedures were pub-
lished in 1973, the number of publications has steadily 
increased until 1985, when it peaked at 60 studies/year for 
the first time (Fig. 2a). Overall, Europe was the biggest 
contributor during these years, closely followed by North 
America (Fig. 2b). After that, the global number of pub-
lications decreased to as little as 22 studies/year in 1995. 
The number of articles originating from Europe and 
North America in particular decreased drastically be-
tween 1985 and 1995. In contrast, research from Asian 
countries increased, surpassing the other continents for 
the first time in 1987 and every year since. A second short 
publication peak was reached in 1997, with 56 publica-
tions/year released, predominantly originating from Asia 
(n = 39, 70%). In the early 2000s, the publication level 
dropped back to its height a decade earlier. Since 2008 
however, there has been an increase of publications every 
year. Despite increased activity in Europe and North 
America, Asia has clearly remained the most active re-
gion. In 2018 for instance, of n = 186 bypass articles pub-
lished, n = 23 (12.4%) originated from European institu-
tions, n = 41 (22.0%) from American institutions, and 
n = 120 studies (64.5%) were written in Asian depart-
ments (Fig. 2, 3).
Regarding the contribution of other continents over 
the entire 50 years that have been investigated, n = 18 
studies were released from a South American institute, 
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Fig. 2. Number of publications per year and 
continent. Annual number of publications 
(a) and annual number of publications per 
continent (b).




On a national level, Japan was found to be the country 
with the most active bypass research community. Japanese 
institutions have cumulatively published 933 articles, fol-
lowed by the USA with 630 articles and China with 232 
articles. Figure 3 shows the number of publications for all 
countries with >5 contributions. When looking at the 7 
countries with the numerically highest contributions 
(those with >50 articles), 5 countries (Germany, Italy, Ja-
pan, Switzerland, and USA) recorded activity in bypass re-
search in the 1970s already and have remained active ever 
since. By contrast, China and Korea started to contribute 
to the field later, and both countries showed distinctively 
increased activity during the past 10 years. China released 










































































































































■ Number of publications





















■ Case reports/case series
■ Technical notes
Fig. 4. Types of articles over time. The bar 
diagram shows the types of studies pub-
lished over time (per annum). Bypass lit-
erature consists predominantly of case re-
ports/case series and to a lesser extend of 
cohort studies, whereas RCTs and meta-
analyses are few and far between. RCTs, 
randomized control trials.
Fig. 3. Number of publications and cumu-
lative citation index according to the coun-
try of origin. The black bar in histogram 
shows the absolute number of publications 
according to the country on the left axis. 
Countries with a contribution of 5 or less 
bypass articles were omitted for better 
readability. The grey bar relates to the right 
axis and shows the absolute number of the 
total cumulative citation index for all arti-
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Fig. 5. a Role of and indication for bypass. 
Relative distribution of publications ac-
cording to the role of bypass (flow augmen-
tation vs. preservation), as well as its distri-
bution over time. b Within publications 
pertaining to flow-augmentation bypass, 
50% of publications were on moyamoya 
vasculopathy. This indication peaked in 
1997 and is constantly increasing since 
2007. Regarding flow-preservation bypass 
(c), aneurysm is by far the most common 
indication (94%), whereas tumour (4%) 
and others (2%) have remained on a con-
sistently low level.




tional articles), and Korea 88/121 articles (73% of the total 
amount of national articles). However, the cumulative cita-
tion index of all published articles is highest for the USA 
(11,528 citations), followed by Japan (10,571) and Canada 
(1,921). The citation index for China (1,330) is lower than 
that of Korea (1,729) and Germany (1,528) (Fig. 3).
Overall (and for every single year) published bypass 
literature is numerically led by case reports/case series (n 
= 1,433) and cohort studies (n = 1,003). Technical notes 
(n = 131) are by far less common, and RCTs (n = 4) and 
meta-analyses (n = 14) are particularly sparse (Fig. 4).
A majority of n = 1,734 (67%) studies were written on 
the topic of flow augmentation, n = 701 (27%) on flow 
preservation, and n = 149 (6%) studies reported on either 
function of the bypass (Fig. 5a). The last category com-
prises studies on surgical techniques, pre- and intraop-
erative imaging techniques, methods for flow measure-
ment, bypass-specific anaesthesiologic considerations, 
and outcomes of bypass series (including surgical com-
plication, long-term patency, or studies on psychological 
changes in bypass patients).
Indications for flow augmentation included moyamoya 
vasculopathy in n = 877 (50%) studies, steno-occlusive dis-
ease in n = 753 (44%) studies, acute stroke in n = 95 (5%) 
studies, and other indications in n = 7 (0.4%) studies 
(Fig.  5b). In steno-occlusive disease, the stenosed or oc-
cluded vessel was the ICA in n = 250 (47%) studies, the 
MCA in n = 92 (17%) studies, combined ICA and MCA 
occlusion in n = 116 (22%) studies, vertebrobasilar occlu-
sion in n = 56 (11%) studies, and other vessels (i.e., anterior 
cerebral artery) in n = 5 (3%) studies. The category “other” 
indications for flow-augmentation bypasses comprises 
studies on refractory vasospasms, encephaloduroarterio-
synangiosis in patients with cerebrovascular complications 
of sickle cell disease, tuberculosis-induced vasculopathy, 
isolated cerebral pan-angiitis, and omental transposition 
for Alzheimer’s disease. Studies reporting on flow-aug-
mentation bypass for acute stroke are relatively sparse. 
Their annual release rate fluctuated between 0 and 5 publi-
cations, without any specific pattern or change over time.
Concerning flow-preservation bypass, the most com-





























Japan China USA Europe
Fig. 6. Trends of bypass indication according to the country. The main indication for the Asian countries of Japan 
(46%) and China (54%) directed towards moyamoya. In contrast, only 22% of all publications originating in the 
USA and 15% of those originating in European countries were published on this indication. Instead, chronic 
steno-occlusive disease is the most commonly investigated indication in Europe (47%), and aneurysm (33%) in 
the USA. “Europe” integrates studies from Germany, Switzerland, France, UK, Italy, the Netherlands, Austria, 





aneurysm surgery (n = 659, 94%), followed by tumour 
surgery (n = 32, 4%) and others (n = 13, 2%) (Fig. 5c). The 
last category (“others”) includes trauma (penetrating 
trauma of the MCA, vertebral artery, ECA, or ICA), post-
traumatic carotid-cavernous fistulae, and thromboem-
bolic or haemorrhagic complications of ICA, MCA, or 
ACA dissection, respectively.
Overall, moyamoya vasculopathy is the most common 
subject for studies originating in Asian countries, that is, 
Japan (46%) and China (54%). By contrast, aneurysm is 
the most common (33%) topic of articles originating in 
the USA, followed by chronic steno-occlusive disease 
(30%). In Europe, the latter is the most frequently report-
ed topic (47%), followed by aneurysm (28%). Figure 6 
shows the distribution of research articles of the top 5 
contributing countries.
With regard to the categorization of “direct versus in-
direct versus combined,” of all articles, the vast majority 
of n = 2,009 (78%) studies reported on direct bypass sur-
gery. In n = 334 (13%) studies, an indirect bypass was 
performed, and n = 198 (8%) studies reported on com-
bined direct/indirect procedures. In the specific setting of 
moyamoya vasculopathy, indirect bypass and combined 
procedures were used to be more popular than direct by-
pass in the second half of the 1990s. However, with the 
ongoing boost of bypass articles from 2009 onwards, di-
rect bypass has clearly emerged as the most frequently 
reported procedure, followed by indirect and combined 
bypass (see online suppl. Fig 1; for all online suppl. mate-
rial, see www.karger.com/doi/10.1159/000517415).
Concerning the categorization “low versus intermedi-
ate versus high flow” instead, most of the analysed studies 
on direct bypass, that is, n = 1,546 (69%), reported on low-
flow bypasses. Publications on high-flow bypasses (n = 
215, 10%) or on intermediate flow (n = 141, 6%) were 
considerably less frequent. Furthermore, n = 58 (3%) 
studies evaluated multiple flow constellations, and in n = 
290 (13%) studies, the authors did not specify flow dy-
namics. More specifically, in the setting of aneurysm sur-
gery, low-flow bypasses dominate the literature, but after 
2008, reports on intermediate- and high-flow bypass have 
become increasingly popular (online suppl. Fig. 2).
With regard to revascularized territory, for flow-aug-
mentation, n = 1,527 (88%) studies investigated revascu-
larization of the anterior circulation, and n = 61 (4%) of 
the posterior circulation. For flow preservation, n = 544 
(78%) studies investigated revascularization of the ante-
rior circulation and n = 114 (16%) of the posterior circu-
lation. N = 134 publications reported series or techniques 
with bypasses in both locations (online suppl. Fig. 3).
The focus of bypass research has changed over time. In 
1970–1979, articles were generally addressed indication 
and technique of bypass surgery, and often written in the 
form of a single-centre personal experience, such as Yas-
argil reporting his series. In the 1980s, studies on bypass 
for chronic steno-occlusive disease peaked, but the results 
of the international multicentre RCT by the EC/IC Bypass 
Study Group showed a failure of EC-IC arterial bypass to 
reduce the risk of ischaemic stroke. About 10 years later, 
moyamoya disease had become an established entity and 
claimed the main attention in bypass research. With en-
dovascular aneurysm therapy becoming more popular in 
2000, bypass in aneurysm surgery was increasingly inves-
tigated until 2011, when the flow diverter was finally ap-
proved by the FDA. In the last decade, moyamoya vascu-
lopathy and stroke prevention in chronic steno-occlusive 
disease have remained the backbone of bypass research 
with a few studies on flow preservation for aneurysm 
treatment. Online suppl. Table. 1 shows the most fre-
quent words used in titles of bypass articles per decade, as 
well as the most frequently cited studies per decade.
Discussion
Our systematic review identified 2,585 clinical publi-
cations on the topic of cerebral bypass surgery. Japan is 
the country where most articles come from, followed by 
the USA and China. However, articles originating in the 
USA are most often cited, followed by Japanese and Ca-
nadian articles. Two-thirds of articles address flow-aug-
mentation bypass and one-third addresses flow-preserva-
tion bypass. The most common indication reported for 
flow augmentation is moyamoya vasculopathy, followed 
by chronic steno-occlusive disease; the most common in-
dication reported for flow preservation is aneurysm sur-
gery. The majority of all publications addressed direct, 
low-flow bypass procedures in the anterior circulation.
Bypass Research over Time
From the first reports in 1971 until 1980, bypass re-
search had a marginal existence. This niche research was 
originally conducted in few European and North Ameri-
can neurosurgical departments and mainly directed to-
wards anatomical and technical aspects of bypass feasibil-
ity. In the decade 1980–1989, publications on flow-aug-
mentation bypass, more specifically on steno-occlusive 
disease, steadily increased, and peaked for the first time 
in 1985. Probably due to the disillusioning results of the 
EC-IC bypass trial published in that year [9], research de-




creased afterwards. The decrease continued in European 
and American departments over the second half of the 
1980s, and from 1987 on, Asian departments took over in 
the numeric lead of bypass articles, focusing predomi-
nantly on the new entity of moyamoya disease. In the de-
cade 1990–1999, bypass research nearly sank into oblivi-
on in Western countries, but remained at a relatively sta-
ble level in Asian departments. In 1997, another peak was 
reached, due to a short-lasting increase of Asian studies 
on indirect and combined bypasses for moyamoya vascu-
lopathy. With the overall number of publications in the 
year 2000 back on the level it used to be 10 years before, 
articles studying bypass in the setting of aneurysm sur-
gery started to be published with increasing popularity. 
The total global research remained more or less stable 
until 2007, followed by a steep increase which can be ex-
plained by 2 reasons: firstly, studies on flow preservation 
increased because complex open aneurysm surgeries 
were probably increasingly challenged by the more wide-
spread availability of endovascular treatments. That ef-
fect lasted until 2011 when the FDA finally approved flow 
diverters for aneurysm treatment. Secondly, studies on 
flow augmentation have drastically risen from 2007 to 
2020, with a short drop in 2012, most likely as a result of 
the publication of the COSS study in 2011 [10]. The steep 
increase in publications parallels an increased activity in 
Asian countries previously not active in bypass research. 
For instance, China and Korea are amongst the most pro-
ductive countries worldwide during the last decade 
(2010–2019), and both countries have substantially con-
tributed to the total global number of bypass literature. 
However, only a minor amount of these articles were re-
leased before 2007 (27% for Korea and 9% for China). 
Because of the second-mentioned reason, clinical bypass 
research has remained a steadily growing field during the 
last decade. The major contributions continue to origi-
nate in Japan, China, and the USA.
Citation Index of Countries and Particular Studies
The young but very active research community in Chi-
na is probably at least partially reflected by the substantial 
differences in the cumulative citation index between na-
tions. American articles reach a higher number of cita-
tions relative to the national cumulative number of pub-
lications (on average 18 citations/article) than a third of 
that (on average 6 citations/article) for research originat-
ing in China. The scientific community had less time to 
discuss and potentially cite the high volume of the rela-
tively recent publications in the latter group. The con-
spicuously high relative citation index of Canada is ex-
plained by the 1985 article of the EC/IC bypass study 
group [9], which was an international multicentre study 
based in Canada and has been cited more than a thousand 
times since. Likewise, exceptionally popular single arti-
cles originating in France [11] (564 citations) and Den-
mark [12] (245 citations) explain the high relative citation 
index in light of a moderate cumulative number of pub-
lications from these countries.
From a qualitative point of view, the numerical in-
crease of bypass literature is predominantly generated by 
a proportional increase of case reports/case series and to 
a lesser extend of cohort studies. A distinctively increased 
pool of published data from these 2 types of studies may 
have led to a subsequent, slight increase of meta-analyses 
in recent years. Divergently, there was no increase in 
RCTs observed.
Flow-Augmentation Bypass
Moyamoya represents the bypass indication with the 
most literature available. The disease “of spontaneous oc-
clusion of the circle of Willis and development of an ab-
normal vascular network at the base of the brain” was first 
recognized as a single clinical entity in 1965, in Japan, fol-
lowed by an international echo in the English literature in 
the years 1968–1970 [13]. However, it started to be a fre-
quent topic of scientific publications only in the early 
1980s, and parallels the increasing number of studies 
originating in Japan and more recently in China. In these 
countries, moyamoya is more common than in Western 
countries [14]. Currently, observational studies provide 
level-4 evidence for indication of bypass surgeries in isch-
aemic moyamoya vasculopathy, for children and adults 
with symptomatic moyamoya and compromised haemo-
dynamics [2]. Observational studies have shown unfa-
vourable clinical outcomes and annual ischaemic stroke 
rate to be as high as 13.3% with untreated patients (those 
not undergoing bypass surgery) [15, 16]. Therefore, ran-
domization of patients would be unethical, and it seems 
highly unlikely that it would be possible to conduct an 
RCT for this indication in the future, to raise the evidence 
to a higher level [4]. However, the value of bypass surgery 
for prevention of recurrence of haemorrhagic stroke in 
patients with moyamoya vasculopathy has been proven 
in an RCT, the “Japanese Adult moyamoya (JAM) Trial” 
[17]. Although statistically marginal, the Japanese Adult 
moyamoya Trial revealed that direct or combined bypass 
surgery on adult patients with haemorrhagic moyamoya 
reduces the rebleeding rate and improves the patient’s 
prognosis during the 5 years after enrolment (level of ev-





despite the number of studies available, the preferred type 
of bypass in these patients remains debated and studies 
continue to report beneficial outcomes with direct, indi-
rect, and combined procedures [4, 18, 19]. These contro-
versies may explain the ongoing research and publication 
activity in this field.
For chronic steno-occlusive (non-moyamoya) disease, 
the situation is different. This has remained a main focus 
of bypass research from the early 1970s until today. The 
aim of these early studies was to report on successful by-
pass surgeries for stroke prevention. Indirect cerebral re-
vascularization methods are and were considered ineffec-
tive for non-moyamoya vasculopathy [4, 20]. Two large 
multicentre prospective RCTs (the EC-IC bypass trial in 
1985 and the COSS study in 2011) investigated if a direct 
STA-MCA bypass (in addition to the best medical treat-
ment) could prevent new ischaemic events. Results of 
these studies showed that bypass surgery did not make a 
significant difference in the incidence of fatal and non-
fatal ischaemic strokes compared to patients under the 
best medical treatment [9, 10]. This may explain the drop 
of bypass articles published after 1985. In contrast, the 
Japanese EC-IC Bypass Trial was a multicentre RCT in-
cluding patients with recent symptomatic haemodynam-
ic cerebral ischaemia from chronic ICA or MCA occlu-
sion. In this trial, a significant reduction of major stroke 
and death in patients receiving bypass plus the best med-
ical therapy was achieved in comparison to best medical 
therapy alone (5.1 vs. 14.3%) [21]. However, findings of 
that study are controversial and publication of the final 
results in a peer-reviewed English-written journal is 
pending [21, 22]. Therefore, it is difficult to include the 
Japanese EC-IC Bypass Trial study results into the gen-
eral evidence base regarding bypass in atherosclerotic dis-
ease [4]. The findings of the still ongoing Chinese Middle 
Cerebral Artery Occlusion Surgery Study [23] are expect-
ed to provide further insights into the role of bypass sur-
gery for steno-occlusive disease. Furthermore, the recent-
ly published American Encephaloduroarteriosynangiosis 
Revascularization for Symptomatic Intracranial Arterial 
Stenosis phase II trial provided the evidence of safety and 
strong signals of efficacy of indirect bypass in addition to 
the best medical management [24], supporting advance-
ment to a consecutive phase IIb/III trial.
Lastly, acute ischaemic stroke as an indication for 
flow-augmentation bypass only comprises a small per-
centage of all articles published on bypass surgery. A few 
older retrospective series reported good outcomes in pa-
tients with emergency bypass for reperfusion of brain tis-
sue at risk (penumbra concept) [25–27]. Today, other re-
vascularization techniques (i.e., drug-induced thrombol-
ysis or endovascular procedures) have become a 
well-established standard. Emergency bypass operations 
in the setting of acute stroke are limited to very specific 
cases (with failure of medical/endovascular revascular-
ization and penumbra tissue to save) and performed in 
highly specialized centres only. Accordingly, contempo-
rary literature primarily comprises only a few case series 
published on that topic [28–30].
Flow-Preservation Bypass
With the establishment of bypasses in the neurosurgical 
armamentarium, neurosurgeons realized that this tech-
nique could be a helpful tool for the treatment of complex 
intracranial aneurysms otherwise not amenable to clipping 
[31, 32]. Angioanatomy of complex aneurysm (size, shape, 
location, etc.) is highly variable and surgical treatment of 
such lesions cannot be reduced to some standard proce-
dures. Therefore, if a bypass is needed for the treatment of 
a complex intracranial aneurysm, revascularization strate-
gies will be tailored depending on the case (aneurysm and 
angioanatomical characteristics). As such, the correspond-
ing literature primarily consists of case series and case re-
ports. The heterogeneity of the disease and the low number 
of cases do not allow for proper randomization, which is 
why it is unlikely that higher evidence derived from an 
RCT will enlighten the field. Interestingly, the topic is more 
popular in Europe and North America than in Asia. An 
increasing popularity of reporting on these bypass opera-
tions almost came to an abrupt end with the FDA approv-
al of flow diverters for aneurysm treatment in 2011. Over 
the subsequent years, the amount of bypass articles pub-
lished on the topic of aneurysm surgery decreased by more 
than 50% (i.e., from 45 studies in 2012 to 24 studies in 
2013). The effect lasted longer in Europe than in North 
America, where a rebound effect was observed already in 
2014. Nevertheless, neurosurgeons have continued to re-
port their experiences with these fascinating cases, and in 
more recent years, the number of publications is increasing 
again. In older days, most of these bypasses were STA-
MCA anastomoses, but with the overall rise of publications 
on bypass for aneurysm surgery in the second half of the 
2000s, reports on the use of arterial or venous grafts to es-
tablish intermediate- and high-flow bypasses have become 
increasingly popular, particularly in the USA.
In contrast to revascularization for aneurysm surger-
ies, bypass in the setting of tumour surgeries is far less 
common; the literature consists of only a few case reports 
and case series. With only a handful of studies older than 
1990 [33–35], 1 to 2 reports/series on the topic have been 




released annually since then, without any observable geo-
graphic predominance. With a few exceptions, most of 
these publications report on direct bypasses in the ante-
rior circulation. Low-flow constructs and interposition 
grafts (intermediate and high flow) are equally reported. 
The reports are limited to patients, for whom radical tu-
mour resection (at the price of arterial scarification) leads 
to improved survival rates with a good quality of life. 
However, recent advances in oncological treatment mo-
dalities nowadays often attest a better risk-benefit ratio 
for partial tumour resection combined with adjuvant ra-
dio-/chemotherapy than complete resection [4]. There-
fore, this indication will probably continue to play a neg-
ligible role in the bypass literature [36, 37].
Strengths and Limitations
With the current comprehensive review, the intention 
was to categorize the clinical literature on cerebral bypass 
procedures in order to analyse trends, for instance on 
how the number of articles increased or decreased ac-
cording to the evidence-based medicine and the corre-
sponding grade of recommendation, how different coun-
tries and continents contributed to the subject, and lastly, 
how the role of and the indication for bypass changed 
over time and differs amongst countries. Despite our sys-
tematic approach and the use of 4 different independent 
databases, we cannot rule out the possibility that we might 
have not identified other relevant studies. Japan is the 
country with the highest activity in bypass research, but 
we were not able to include studies written in Japanese 
unless they have been published with an English abstract. 
Furthermore, categorization of studies is not always clear. 
For instance, certain articles reported surgical series for 
various indications and using several bypass techniques. 
Therefore, not all studies could be assigned to 1 single 
type of bypass or a given indication. Unfortunately, cat-
egorization according to key words was not possible, 
since some studies did not use any key words at all, or they 
were not meaningful within our specific context (i.e., ce-
rebral revascularization, bypass, etc.). Therefore, we plot-
ted word clouds for words used in the titles of the studies. 
Lastly, for the purpose of this review, all published articles 
that met the inclusion criteria were included without 
weighing the individual studies. Therefore, a simple case 
report equals the weight of a more meaningful RCT in our 
descriptive analysis. For this reason, we additionally de-
termined the citation index of all the included articles. 
With the aim to provide an overview of the past and cur-
rent trends in bypass research, this is likely more adequate 
than a critical appraisal of all studies.
Conclusion
This systematic review reported on 2,585 clinical pub-
lications on the topic of cerebral bypass surgery. These 
studies have become increasingly popular in the last de-
cades. Two-thirds of the articles address flow-augmenta-
tion bypass, whereas one-third addresses flow-preserva-
tion bypass.
Japan is the country with the highest number of pub-
lished articles, followed by the USA and China. In turn, 
articles from the USA are cited most frequently, followed 
by Japan and Canada. The majority of all publications ad-
dressed direct, low-flow bypass procedures in the ante-
rior circulation. The most common indication reported 
for flow augmentation is moyamoya vasculopathy, fol-
lowed by chronic steno-occlusive disease. Since the intro-
duction of moyamoya as a distinct pathologic entity, 
Asian countries in particular have a very active commu-
nity regarding this disease, with an increasing number of 
articles published every year. Studies on bypass for chron-
ic steno-occlusive disease peaked in the 1980s, but have 
remained the main focus of bypass research particularly 
in many European departments.
The most common indication reported for flow pres-
ervation is aneurysm surgery. During the past few years, 
these bypasses are reported more frequently again. In the 
USA, bypass for complex aneurysm surgery is most fre-
quently investigated. An increasing popularity of report-
ing on these bypass operations markedly decreased after 
the FDA approval of flow diverters for aneurysm treat-
ment in 2011. In the subsequent years, the amount of by-
pass articles published on the topic of aneurysm surgery 
has slightly increased again.
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